Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 109   

Articles published

JNJ 98.90 +0.62 (0.63%)
price chart
Is Johnson & Johnson a Buy Now?
Johnson & Johnson (NYSE:JNJ), the pharmaceutical giant known for such iconic brands as Band-Aid, Listerine, and Tylenol, recently reported second-quarter earnings with mixed results.
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2015  PR Newswire (press release)
Johnson & Johnson's link to PP: Tell Me It Ain't So
I have one favorite baby lotion. My mom bought it. The smell of it trips all of my maternal triggers. I want to unwrap a chubby baby and slather it all over their little bodies.
Johnson & Johnson (JNJ) Stock Earnings Estimates Upped at Leerink
The firm reiterated its "outperform" rating and a price target of $115 on the holding company stock. Johnson & Johnson has successfully generated positive momentum and reaccelerating growth in 2013 after suffering several years of below-industry growth ...
Johnson & Johnson Raised to "Strong-Buy" at Vetr Inc. (JNJ)  Dakota Financial News
Johnson & Johnson Upgraded to "Buy" by Zacks (JNJ)  sleekmoney
Johnson & Johnson's new health risk assessment product aimed at improving user ...
My Health Discovery, Johnson & Johnson Johnson & Johnson Health and Wellness Solutions, which focuses on behavior modification and consumer engagement through digital health coaching, has revealed a new product, My Health Discovery.
'Johnson & Johnson' returning to country station KBULL 93
Salt Lake City country station KUBL-FM, better known as KBULL 93, is bringing back the veteran morning team Johnson & Johnson to their old morning slot, starting Monday. Tommy Johnson and Joe Johnson first came to KBULL 93 in 1997, and worked in ...
Johnson & Johnson Return To Salt Lake City  Radio Ink
3 Reasons Johnson & Johnson Stock Could Rise
There are few companies these days that can truly be classified as "safe" investments, but I'd opine that healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is among the elite class of companies that still fits the mold. Apparently, I'm not alone ...
5 Figures to Monitor Ahead of Johnson & Johnson's Second-Quarter Report  Motley Fool
3 Reasons Why Investors Should Keep Johnson & Johnson (JNJ) Stock
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Higher
TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, notable return on equity ...
Is this FBI Investigation a Threat to Johnson & Johnson?
The FBI is investigating a surgical device used on tens of thousands of women each year, and this could be bad news for Johnson & Johnson (NYSE:JNJ). Last year, Johnson & Johnson voluntarily stopped selling power morcellators, a surgical instrument ...
Johnson & Johnson HIV Vaccine Can Block Virus In 50 Percent Of Monkeys In Trial
Johnson & Johnson announced on July 2 that it has collaborated with an international team of experts to conduct a study and test the effectiveness of an HIV vaccine regimen on non-human primates.
Johnson & Johnson's HIV Vaccine Shows Promise in Trial  Clapway
Amazing results from AIDS vaccine test, Johnson & Johnson is now getting ...  Morning Ticker
Johnson & Johnson expects sales 'momentum' in Vision Care
But the Jacksonville-based contact lens maker usually registers just a blip on Johnson & Johnson's quarterly earnings report.